GLABF (Gemina Laboratories) Total Liabilities: $4.47 Mil (As of Oct. 2025)


What is Gemina Laboratories Total Liabilities?

Gemina Laboratories GLABF -27.59% Total Liabilities is $4.47 Mil as of Oct. 2025. The stock has 2 warning signs investors should review.

Gemina Laboratories's Total Liabilities for the quarter that ended in Oct. 2025 was $4.47 Mil.

Gemina Laboratories's quarterly Total Liabilities increased from Apr. 2025 ($3.99 Mil) to Jul. 2025 ($4.33 Mil) and increased from Jul. 2025 ($4.33 Mil) to Oct. 2025 ($4.47 Mil).

Gemina Laboratories's annual Total Liabilities increased from Jan. 2023 ($1.45 Mil) to Jan. 2024 ($2.27 Mil) and increased from Jan. 2024 ($2.27 Mil) to Jan. 2025 ($4.08 Mil).

Gemina Laboratories Total Liabilities Historical Data

* Premium members only.

The historical data trend for Gemina Laboratories's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories Total Liabilities Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24 Jan25
Total Liabilities
1.86 0.38 1.45 2.27 4.08

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.63 4.08 3.99 4.33 4.47

Gemina Laboratories Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Gemina Laboratories's Total Liabilities for the fiscal year that ended in Jan. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3.96+(0.122+-1.1102230246252E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=4.08

Total Liabilities=Total Assets (A: Jan. 2025 )-Total Equity (A: Jan. 2025 )
=0.999--3.082
=4.08

Gemina Laboratories's Total Liabilities for the quarter that ended in Oct. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=4.47+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=4.47

Total Liabilities=Total Assets (Q: Oct. 2025 )-Total Equity (Q: Oct. 2025 )
=0.794--3.676
=4.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $4.47 Mil mean?
Gemina Laboratories (GLABF) has a Total Liabilities of $4.47 Mil as of Oct. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Gemina Laboratories and its competitors.
Is Gemina Laboratories' Total Liabilities too high?
Gemina Laboratories' current Total Liabilities is $4.47 Mil.
How does Gemina Laboratories' Total Liabilities compare to VRTX and REGN?
Gemina Laboratories' Total Liabilities of $4.47 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Gemina Laboratories and its competitors. Gemina Laboratories's current Total Liabilities is $4.47 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gemina Laboratories stock overvalued right now?
Gemina Laboratories (GLABF) has a current Total Liabilities of $4.47 Mil. The current Total Liabilities is $4.47 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Gemina Laboratories (GLABF), the current Total Liabilities is $4.47 Mil as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gemina Laboratories Business Description

Address 3600 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.